Changzhou Beam Diagnotics Automation Co. Ltd. was founded in December 2013, the company is located in the beautiful and fertile Yangtze River in Golden Triangle area, in suxichang metropolitan area, the transportation is very convenient; BeamDiag engages in independent research and development, the streaming technology products production and sales of products related to pretreatment preparation instrument and other biotechnology products by flow cytometry.
The company has a high level, high quality, strong professional talents of the entrepreneurial team, the leading passers-by graduated from the Nanjing University of Aeronautics & Astronautics. Core team entrepreneurial experience, accumulated a wealth of experience, the formation of a scientific management system. Team members are young and full of vitality, with innovative awareness and the courage to meet the challenges. Have a good sense of social responsibility, willing to localization, automation, miniaturization and modularization contribute China high-end medical equipment of power.
As a general instrument, the flow technology platform can be widely used in many fields. Flow cytometry and analytical techniques have been widely used in the fields of immunology, hematology, oncology, cell biology, biochemistry and other scientific research and clinical medicine.
In the field of medicine, can be used in drug toxicology research, blood disease diagnosis, immune system monitoring, early cancer screening, clinical and efficacy evaluation. In late 80s, the clinical application of the start, the determination of blood CD4 + T cells in the number of patients with HIV disease, open flow cytometry applied to a new era of clinical. Clinical detection of HIV, leukemia, immune typing and analysis, HLA-B27 detection analysis, flow detection technology are done as the gold standard for quantitative detection. With the rapid development of electronic technology, optical technology, physical photoelectric measurement technology and electronic computer technology and cell fluorescence chemical technology and monoclonal antibody technique, flow cytometry to gradually replace the non coherent light source laser source, overall miniaturization degree, instrument automation has been greatly improved, the realization of multi laser multicolor fluorescence the analysis of a single experiment can get up to 17 parameters, greatly improving the sensitivity and accuracy of experiment and speed. And, from the relatively quantitative development to the absolute quantitative analysis of flow cell, from the analysis of the cell membrane components to the intracellular composition analysis.
Regulation consulting and service platform of medical device
Large dealers in the field of medical instruments
The only domestic R & D, production flow cytometry reagents manufacturers